Home Ingredients Diosmin
Cardiovascular

Diosmin

Evidence Level
Moderate
4 Clinical Trials
8 Documented Benefits
3/5 Evidence Score

Diosmin is a flavonoid (specifically a flavone glycoside) derived from citrus fruits, primarily orange peel. It's used widely in Europe (often combined with hesperidin in a 90:10 ratio called 'Daflon' or MPFF — Micronized Purified Flavonoid Fraction) for chronic venous insufficiency, varicose veins, and hemorrhoids. In Europe, MPFF is a prescription drug for venous conditions; in the US, diosmin is sold only as a dietary supplement (not FDA-approved as a drug). Meta-analyses support effectiveness for venous health and hemorrhoid management. Mechanism involves improved venous tone, reduced capillary permeability, lymphatic drainage support, and modest anti-inflammatory effects on vascular tissue. The honest framing: one of the best-evidenced botanical supplements for the specific venous and hemorrhoid indications; not useful for general health applications outside venous/lymphatic conditions; note that the supplement-grade products in the US don't carry the same regulatory standing as European prescription medications.

Studied Dose 900 mg diosmin + 100 mg hesperidin (1,000 mg MPFF) once or twice daily; acute: 2,000-3,000 mg/day; CVI: 1,000 mg/day.
Active Compound Diosmin (citrus flavone glycoside), usually with hesperidin in a 90:10 ratio (MPFF, Micronized Purified Flavonoid Fraction).

Benefits

Chronic venous insufficiency symptom reduction

Meta-analyses of randomized trials indicate the micronized diosmin plus hesperidin combination (MPFF) reduces symptoms of chronic venous insufficiency including leg pain, heaviness, swelling and tiredness. The Cochrane review rates the edema benefit moderate-quality and other venous outcomes low-quality, and most of this evidence used the MPFF combination rather than diosmin on its own.

Supported by Trial 1, Trial 2

Hemorrhoid symptom management

A meta-analysis of flavonoids, largely the MPFF combination, reports an apparent reduction in hemorrhoid bleeding and persistent symptoms, though the authors caution that methodological limitations, heterogeneity and possible publication bias temper the finding. Most trials tested diosmin plus hesperidin, not diosmin alone. Often used alongside topical products and lifestyle changes.

Supported by Trial 2

Varicose vein symptoms

Clinical evidence supports diosmin for reducing symptoms associated with varicose veins — leg heaviness, edema, night cramps, and discomfort. Does not eliminate visible varicose veins but improves quality of life symptoms.

Supported by Trial 3

Improved venous tone

Diosmin increases venous tone and reduces venous distensibility — mechanism explaining the symptomatic improvements in venous insufficiency. Direct vascular effects rather than purely anti-inflammatory action.

Supported by Trial 1, Trial 2

Reduced capillary permeability

Diosmin strengthens capillary integrity and reduces capillary leakage — mechanism contributing to reduced leg swelling and improved tissue health. Important for chronic venous disease where capillary fragility plays a role.

Supported by Trial 1, Trial 2

Lymphatic drainage support

Beyond venous effects, diosmin supports lymphatic drainage — important for conditions involving fluid retention and lymphatic compromise. Mechanism complements the venous tone effects.

Supported by Trial 3, Trial 1

European prescription drug status

Diosmin/MPFF (Daflon) is widely available as a prescription drug in European countries including France, Spain, Portugal, and others, with established clinical use protocols for venous disease and hemorrhoids. In the United States, diosmin is available only as a dietary supplement (not FDA-approved as a drug). The regulatory difference matters: European prescription standing supports the clinical evidence quality, while US supplement-grade products vary in manufacturing standards.

Supported by Trial 2, Trial 1

Generally not useful outside venous applications

Diosmin has minimal evidence for general cardiovascular, immune, or other applications outside the specific venous/hemorrhoid indications. The honest framing: this is a specific-indication supplement, not a broad-spectrum health product.

Supported by Trial 1, Trial 3

Mechanism of action

1

Venous tone enhancement

Diosmin prolongs the vasoconstrictor effect of noradrenaline on the venous wall, increasing venous tone and reducing venous distensibility. Primary mechanism for the chronic venous insufficiency applications.

2

Capillary stabilization

Diosmin reduces capillary hyperpermeability and increases capillary resistance — mechanism for reduced leg swelling and improved tissue health in venous disease.

3

Lymphatic flow improvement

Diosmin enhances lymphatic drainage through increased contractility of lymphatic vessels. Mechanism contributes to edema reduction and overall venous-lymphatic balance.

4

Anti-inflammatory effects on vascular tissue

Diosmin reduces leukocyte adhesion to vascular endothelium and modulates inflammatory cytokines locally. Mechanism complements the structural venous effects for reducing chronic venous disease symptoms.

Clinical trials

1
Chronic venous insufficiency evidence syntheses
PubMed

Multiple pooled analyses of randomized trials show diosmin/MPFF significantly reduces chronic venous insufficiency symptoms over 6+ months.

Clinical population described in trial publication.

Multiple pooled analyses of randomized trials show diosmin/MPFF significantly reduces chronic venous insufficiency symptoms over 6+ months. The Cochrane review rated this moderate-quality for edema and low-quality for other outcomes, with notable variation between trials.

2
Hemorrhoids: meta-analysis of flavonoids (largely MPFF)
PubMed

Clinical trials show diosmin/MPFF reduces hemorrhoid symptoms (bleeding, pain, inflammation) in 4-7 days of higher-dose acute protocols.

Clinical population described in trial publication.

Clinical trials show diosmin/MPFF reduces hemorrhoid symptoms (bleeding, pain, inflammation) in 4-7 days of higher-dose acute courses, although the meta-analysis authors caution that methodological limitations and possible publication bias temper the result. Most trials used the diosmin plus hesperidin combination rather than diosmin alone.

3
Varicose vein and venous symptoms: MPFF meta-analysis
PubMed

Trials in adults with varicose veins show diosmin improves leg heaviness, edema, and discomfort.

Clinical population described in trial publication.

Trials in adults with varicose veins show diosmin improves leg heaviness, edema, and discomfort. Does not eliminate visible varicose veins but improves quality of life symptoms.

4
Safety from long-term European prescription and clinical use (usage record, not a controlled trial)

European medical food usage establishes long-term safety profile through extensive clinical and prescription use.

Clinical population described in trial publication.

European medical food usage establishes long-term safety profile through extensive clinical and prescription use. Side effects rare and typically mild.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated across clinical trial use.
Mild GI discomfort possible at higher doses.
Occasional headache or dizziness reported.
European prescription medical food use establishes long-term safety profile.
Pregnant women: avoid during first trimester; safer in later pregnancy under medical guidance.

Important Drug interactions

Generally minimal drug interactions documented.
Theoretical caution with anticoagulants — modest antiplatelet effects possible.
May complement compression therapy for venous insufficiency without interaction concerns.
No significant interactions with common cardiovascular medications.
Consult healthcare providers when combining with prescription medications for venous or hemorrhoid conditions.

Featured in these supplement guides

Circulation & Varicose Veins→

More Cardiovascular Ingredients

Cardiovascular
Potassium
Potassium is the most abundant intracellular cation in the human body and an essential min…
Cardiovascular
CoroWise® (Plant Sterols for Cholesterol — Cargill)
CoroWise is Cargill's brand of plant sterols (phytosterols), which carry an FDA-authorized…
Cardiovascular
Omega-3 Fatty Acids
Omega-3 fatty acids, primarily eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), an…
Cardiovascular
CoEnzyme Q10
Coenzyme Q10 (CoQ10) is a lipid-soluble compound essential to mitochondrial ATP production…

Frequently asked questions about Diosmin

What is diosmin used for?

Diosmin is a citrus flavonoid widely used (often with hesperidin) for venous health, including chronic venous insufficiency, varicose veins, leg swelling, and hemorrhoids. It supports vein tone and healthy circulation.

Does diosmin help with hemorrhoids and varicose veins?

Diosmin, especially the micronized diosmin-hesperidin combination, has notable research for easing symptoms of venous insufficiency, varicose veins, and hemorrhoids, such as swelling, heaviness, and discomfort.

How much diosmin should I take?

A common regimen is 450 mg diosmin with 50 mg hesperidin (a 900 mg total daily dose split into two), reflecting the studied micronized formula. For acute hemorrhoid flares, higher short-term doses are sometimes used. Follow labeling.

Is diosmin safe?

Diosmin is generally well tolerated; occasional mild digestive upset or headache can occur. It is widely used for vein health. Pregnant or breastfeeding women and those on medication should check with a doctor.

What is Diosmin?

Diosmin is a flavonoid (specifically a flavone glycoside) derived from citrus fruits, primarily orange peel. It's used widely in Europe (often combined with hesperidin in a 90:10 ratio called 'Daflon' or MPFF — Micronized Purified Flavonoid Fraction) for chronic venous insufficiency, varicose veins, and hemorrhoids.

What is the recommended dosage of Diosmin?

The clinically studied dose is 900 mg diosmin + 100 mg hesperidin (1,000 mg MPFF) once or twice daily; acute: 2,000-3,000 mg/day; CVI: 1,000 mg/day. Always follow the product label and check with a healthcare provider for personal advice.

Is Diosmin safe, and does it have side effects?

For most healthy adults, Diosmin is well tolerated at studied doses. Reported effects can include: Generally well-tolerated across clinical trial use. Mild GI discomfort possible at higher doses. It may also interact with some medications. Diosmin is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Diosmin interact with any medications?

Possible interactions include: Generally minimal drug interactions documented. Theoretical caution with anticoagulants — modest antiplatelet effects possible. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Diosmin?

NutraSmarts rates the evidence for Diosmin as Moderate (3 out of 5). It is backed by 4 clinical trials and 4 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(4 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Martinez-Zapata MJ, Vernooij RW, Uriona Tuma SM, Stein AT, Moreno RM, Vargas E, et al. Phlebotonics for venous insufficiency. Cochrane Database Syst Rev. 2016;4(4):CD003229. doi: 10.1002/14651858.CD003229.pub3.PubMedUsed to support: Supports CVI claim (moderate quality): Cochrane review found phlebotonics (including diosmin/MPFF) probably reduce edema and some venous symptoms versus placebo, but with moderate-to-low certainty evidence and notable heterogeneity. Frames the benefit as real but modest.
  2. Alonso-Coello P, Zhou Q, Martinez-Zapata MJ, Mills E, Heels-Ansdell D, Johanson JF, et al. Meta-analysis of flavonoids for the treatment of haemorrhoids. Br J Surg. 2006;93(8):909-20. doi: 10.1002/bjs.5378.PubMedUsed to support: Supports hemorrhoid-bleeding claim: meta-analysis found flavonoids (largely diosmin-based MPFF) reduced the risk of bleeding and persistent symptoms in hemorrhoidal disease, though the authors caution about methodological limitations of the included trials.
  3. Kakkos SK, Nicolaides AN. Efficacy of micronized purified flavonoid fraction (Daflon) on improving individual symptoms, signs and quality of life in patients with chronic venous disease: a systematic review and meta-analysis of randomized double-blind placebo-controlled trials. Int Angiol. 2018;37(2):143-54. doi: 10.23736/S0392-9590.18.03975-5.PubMedUsed to support: Supports CVI symptom/edema claim: meta-analysis of placebo-controlled RCTs showing MPFF (diosmin + hesperidin) improved leg pain, heaviness, cramps, edema and quality of life in chronic venous disease. Consistent with a moderate symptomatic benefit.
  4. Coleridge-Smith P, Lok C, Ramelet AA. Venous leg ulcer: a meta-analysis of adjunctive therapy with micronized purified flavonoid fraction. Eur J Vasc Endovasc Surg. 2005;30(2):198-208. doi: 10.1016/j.ejvs.2005.04.017.PubMedUsed to support: Meta-analysis of five randomized studies (723 patients) reporting that MPFF (diosmin plus hesperidin) added to compression and local care improved venous leg ulcer healing at six months (about 32 percent relative improvement). Several of the pooled studies compared MPFF with conventional care alone rather than with placebo, and the tested agent is the combination fraction, not diosmin on its own, so this is adjunctive, combination evidence.